ArticlePhotodermatology, photoimmunology & photomedicine2019
Skin cancer projections and cost savings 2014-2045 of improvements to the Danish sunbed legislation of 2014.
Article in Photodermatology, photoimmunology & photomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Cost-Effectiveness of Primary Prevention Interventions for Skin Cancer: An Updated Systematic Review.Applied health economics and health policy · 2024Pooled it
- Cost-effectiveness of a policy-based intervention to reduce melanoma and other skin cancers associated with indoor tanning.The British journal of dermatology · 2022Article
- Updated fraction of cancer attributable to lifestyle and environmental factors in Denmark in 2018.Scientific reports · 2022Article
- Association of Indoor Tanning Regulations With Health and Economic Outcomes in North America and Europe.JAMA dermatology · 2020Article
- Skin cancer projections and cost savings 2014-2045 of improvements to the Danish sunbed legislation of 2014.Photodermatology, photoimmunology & photomedicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSunbed use increases the risk of skin cancer. The Danish sunbed legislation (2014) did not include an age limit.
aimTo model skin cancer incidences and saved costs from potential effects of structural interventions on prevalence of sunbed use. MATERIALS AND
methodsSurvey data from 2015 were collected for 3999 Danes, representative for the Danish population in regards to age, gender and region. Skin cancer incidences were modelled in the Prevent program, using population projections, historic cancer incidence, sunbed use exposure and relative risk of sunbed use on melanoma.
resultsIf structural interventions like an age limit of 18 years for sunbed use or complete ban had been included in the Danish sunbed legislation in 2014, it would have reduced the annual number of skin cancer cases with 455 or 4177, respectively, while for the entire period, 2014-2045 the total reductions would be 3730 or 81 887 fewer cases, respectively. The cost savings from an age limit or ban, respectively, are 9 and 129 millions € during 2014-2045.
conclusionLegislative restrictive measures which could reduce the sunbed use exists. Danish politicians have the opportunity, supported by the population, to reduce the skin cancer incidence and thereby to reduce the future costs of skin cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.